Enzo Biochem, Inc. Stock

Equities

ENZ

US2941001024

Biotechnology & Medical Research

Delayed Nyse 10:22:23 2024-04-29 EDT 5-day change 1st Jan Change
1.06 USD +0.95% Intraday chart for Enzo Biochem, Inc. -2.75% -23.74%
Sales 2022 107M 146M Sales 2023 31.06M 42.4M Capitalization 73.6M 100M
Net income 2022 -18M -24.57M Net income 2023 20M 27.3M EV / Sales 2022 1.07 x
Net cash position 2022 1.02M 1.39M Net cash position 2023 75.38M 103M EV / Sales 2023 -0.06 x
P/E ratio 2022
-6.24 x
P/E ratio 2023
3.59 x
Employees 185
Yield 2022 *
-
Yield 2023
-
Free-Float 75.81%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.48%
1 week-2.75%
Current month-16.54%
1 month-15.20%
3 months-16.54%
6 months-24.82%
Current year-23.74%
More quotes
1 week
1.04
Extreme 1.04
1.11
1 month
1.04
Extreme 1.04
1.30
Current year
1.04
Extreme 1.04
1.50
1 year
1.04
Extreme 1.04
2.74
3 years
1.00
Extreme 1
4.15
5 years
1.00
Extreme 1
4.85
10 years
1.00
Extreme 1
12.04
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 10-12-31
Founder 81 76-07-31
Director of Finance/CFO 47 -
Members of the board TitleAgeSince
Chairman 64 23-10-25
Director/Board Member 58 20-11-16
Director/Board Member 50 22-01-02
More insiders
Date Price Change Volume
24-04-29 1.06 +0.95% 2 805
24-04-26 1.05 -1.87% 114,913
24-04-25 1.07 +0.94% 74,257
24-04-24 1.06 -2.75% 77,230
24-04-23 1.09 0.00% 76,123

Delayed Quote Nyse, April 29, 2024 at 10:22 am

More quotes
Enzo Biochem, Inc. is focused on molecular diagnostics and has a portfolio of technical platforms and reagent sets supporting a diverse range of biomedical research and translational science needs. The Company operates through the product segment, which manufactures, develops and markets products and tools for clinical research, translational research, drug development and bioscience research customers worldwide. The Company is engaged in product development and manufactures and supplies a comprehensive portfolio of products, including antibodies, genomic probes, assays, biochemicals and proteins. The Company's products and technologies are used in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry and small molecule chemistry. Its life science division supports the work of research centers and industry partners. It has built a portfolio of intellectual property assets, comprised of around 457 owned patents worldwide.
More about the company